Solid-state and basic physicochemical data
Occurrence in Plant and Products
- Present in kratom leaves at variable levels, typically 0.1–1.0% w/w of dry leaf material.
- Relative abundance is often comparable to or slightly lower than mitragynine in most chemotypes.
- Commercial extracts and products show broad ranges; some U.S. market powders report
0.05–0.8% of dry weight.
- Detected in brewed teas and liquid extracts, showing efficient extraction into consumer preparations.
Analytical Methods
Quantitation of speciogynine has been incorporated into multi-analyte LC–MS/MS and HRMS methods:
- Sharma et al. (2019): Ten-alkaloid UPLC–MS/MS panel for plant and product QC.
- Kamble et al. (2021): Eleven-alkaloid plasma PK method applied to kratom products.
- Manwill et al. (2022): HRMS-based chemotyping study distinguishing mitragynine isomers.
- Standard reference materials are available (e.g., Cayman Chemical, Cerilliant) for validated quantitation.
Limitations & Notes
- Speciogynine co-elutes with related diastereomers (mitragynine, speciociliatine),
requiring optimized chromatographic separation.
- Reported levels differ between fresh leaves, dried powders, and processed extracts.
- Limited pharmacological data — focus remains on occurrence and analytical reporting.
- Useful as a marker in differentiating kratom chemotypes alongside mitragynine and speciociliatine.